Skip to main content

Healthcare costs

Close up of man hands using lancet to check blood sugar level with stack of coins. Health care cost concept.

10-17-2022 | Healthcare costs | News

Cost drives one in six US adults to ration insulin

Findings from a nationally representative US survey show that a substantial minority of people with diabetes ration their use of insulin because of issues with affordability.

Piggy bank balancing on seesaw over a bottle of pills

10-04-2022 | Healthcare costs | News

First-line SGLT2 inhibitors, GLP-1 receptor agonists ‘not cost effective’

The authors of a modeling study say that the price of SGLT2 inhibitors and GLP-1 receptor agonists would need to fall “by at least 70%” for them to be cost effective as first-line treatments in the USA.

10-22-2021 | Healthcare costs | News

SGLT2 inhibitor cost-effectiveness feasible in low-, middle-income countries

Reducing the cost of SGLT2 inhibitors by around 17% would make them cost-effective for use in people with type 2 diabetes in low- and middle-income countries, study findings indicate.

12-17-2020 | Canagliflozin | News

Model demonstrates cost-effectiveness of canagliflozin in type 2 diabetes

Adding canagliflozin to current standard of care improves survival, increases quality-adjusted life–years, and reduces treatment costs for people with type 2 diabetes treated in England over a 10-year period, research suggests.

11-20-2018 | Healthcare costs | News

High-deductible insurance linked to delays in care for diabetes complications

Compulsory enrollment in a high-deductible health insurance plan is associated with significant delays in seeking care for macrovascular complications among people with diabetes, US research shows.